North America Patient Blood Management Market Outlook (2025-2035)
The North America Patient Blood Management market is witnessing strong momentum, driven by rising surgical procedures, advancements in blood management technologies, and increased awareness around evidence-based transfusion practices. Hospitals and healthcare institutions are prioritizing patient safety and cost optimization, leading to greater investments in blood management solutions. North America, particularly the United States, leads the global landscape with substantial adoption of automation and digital tools in transfusion and blood conservation protocols. Major players are innovating in blood storage devices, diagnostics, and software solutions to address changing regulatory requirements and clinical needs. As the prevalence of chronic diseases increases and the healthcare sector digitalizes, demand for efficient blood management is expected to surge, propelling market growth through 2035.
Latest Market Dynamics
Key Drivers
Increased elective surgeries and trauma cases, necessitating robust blood inventory and management solutions. In June 2024,
enhanced its blood management suite to support growing demands in surgical centers.
Regulatory push for patient blood management (PBM) adoption to reduce unnecessary transfusions and improve outcomes. In July 2024, B. Braun Melsungen AG collaborated with major US hospital networks to implement PBM programs.
Key Trends
Integration of artificial intelligence and predictive analytics in blood management software. In August 2024, Fresenius SE launched AI-powered data solutions for hospital transfusion safety.
Rising demand for minimally invasive blood conservation technologies. Terumo Corporation's new intraoperative cell salvage device, released in July 2024, sets a new benchmark for procedure blood loss minimization.
Key Opportunities
Growing partnership opportunities with digital health platforms to deliver remote patient monitoring and blood status assessments. In June 2024, Bio-Rad Laboratories entered a strategic partnership for digital PBM integration.
Expansion into underserved markets and ambulatory care settings, where blood management protocols are not yet standardized. Mediware Information Systems rolled out cloud-based PBM tools for outpatient centers in July 2024.
Key Challenges
Operational complexities in standardizing PBM protocols across diverse healthcare facilities. Baxter International faced hurdles in implementing centralized PBM across regional networks in 2024.
Data privacy and security concerns with cloud-based PBM applications and integration of patient records, as seen during Immucor Inc.'s cyber risk management rollout in July 2024.
Key Restraints
High initial investment and maintenance costs for advanced PBM technologies, restricting adoption among small and mid-sized providers. Macopharma SA reported slower penetration in rural clinics in June 2024.
Reluctance to transition from legacy blood management systems to digital solutions due to workforce training needs, as seen with Grifols S.A.’s 2024 transition support program.
In 2025, the North America Patient Blood Management market by type is led by Instruments, which constitute the largest segment at 35%. This is followed by Blood Processing Devices at 25% and Software at 15%, with the remaining share distributed among Blood Transfusion Devices, Blood Storage Devices, and Accessories. The dominance of Instruments is attributed to the high demand in surgical and trauma care settings. Strong investments in automation and workflow integration are additionally fueling the adoption of advanced devices. Blood Processing Devices are witnessing robust growth due to technological upgrades and clinical differentiation in health systems. Software solutions, while still developing, are steadily increasing their footprint with the surge in data-driven blood management and analytics.
Diagnostics & Testing represents the largest application segment, accounting for 30% of the market in 2025. Blood Conservation follows closely at 25%, while Blood Collection stands at 20%. The prominence of Diagnostics & Testing reflects the growing emphasis on patient safety and proactive anemia management prior to surgery. Blood Conservation's share is driven by procedural advancements and clinical protocols favoring minimized transfusions. Blood Collection is benefitting from innovations in rapid diagnostics and efficient collection systems, especially in high-volume hospitals and trauma centers. Collectively, these applications reveal the shift towards outcome-based blood management strategies across North America.
The North America Patient Blood Management market revenue has experienced consistent growth from 2020, projected to reach 5,520 Million USD by 2025 and 12,400 Million USD by 2035. The chart highlights a healthy CAGR, reflecting increasing investments in healthcare infrastructure, regulatory mandates, and a shift toward preventive management. Key contributors to revenue expansion include large hospital systems adopting enterprise-wide PBM solutions and the integration of AI-driven diagnostics. Future momentum is expected from emerging outpatient care models and adoption in smaller healthcare facilities.
Year-on-year growth for the North America Patient Blood Management market remains robust, peaking at 18.7% in 2025, driven by major hospital and government procurement programs. The growth rate gradually moderates to a steady 3.3% by 2035 as market penetration matures and competition stabilizes. Early years (2020-2026) see a strong upward momentum attributed to technology adoption and changing clinical practices, while later years reflect consolidation and process optimization. This trajectory underlines the evolving nature of the market and the ongoing value seen in PBM investments.
In 2025, the United States dominates the North America Patient Blood Management market with a commanding 70% share, reflecting its advanced healthcare infrastructure, strong government regulation, and widespread adoption of PBM protocols. Canada represents 20% of the market, benefitting from significant recent investments in hospital blood safety initiatives. Mexico accounts for 10%, primarily due to its growing private hospital sector and increasing awareness campaigns. The chart reinforces the primacy of the US while highlighting emerging opportunities in Canada and Mexico.
The competitive landscape is led by Haemonetics Corporation with a 21% share, followed by Fresenius SE & Co. KGaA at 17%, and Terumo Corporation at 14%. These leading players maintain their edge through extensive R&D and strategic collaborations with major hospital groups. B. Braun Melsungen AG and Baxter International Inc. round out the top five, collectively accounting for an additional 22%. Smaller innovators and niche technology providers occupy the remaining share, focusing on specialty PBM software and devices.
Major hospitals and health systems are the primary buyers, accounting for 40% of the market in 2025. Outpatient care centers, reflecting the trend toward ambulatory care, represent 25%. Blood banks and diagnostic laboratories jointly constitute 20%, while smaller clinics and specialized surgical centers make up the remainder. The chart demonstrates the ongoing centrality of large hospitals in driving PBM market demand, even as decentralized and outpatient models expand their influence.
August 2024: Fresenius SE debuted predictive analytics modules for transfusion safety amid expanded US hospital network adoption.
Frequently Asked Questions
About the Author
Lily
Senior Market Research Analyst
Lily is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Lily brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Lily has helped organizations translate data into actionable growth strategies.
